Skip to main content
Log in

Recurrent malignant glioma: detection with131I labeled monoclonal antibody G-22, positron emission tomography and magnetic resonance imaging

  • Case Report
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

A 45-year-old man with suspected recurrent malignant glioma was evaluated by magnetic resonance imaging (MRI), positron emission tomography (PET) and131I labeled monoclonal antibody G-22 (G-22) scan. Following Gadolinium-DTPA, a Tl-weighted spin echo image (TR 500 msec, TE 20 msec) demonstrated a large mass with an irregular margin in the left temporo-parietal area. An18F labeled fluorodeoxyglucose PET study demonstrated marked accumulations in the left temporo-parietal area. Serial131I-G-22 scintigraphy was obtained for a week after the injection. The uptake was most increased on the 2nd day after the injection.131I G-22 was specific for tumor-associated antigens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Tyler JL, Diksic M, Villemure JG, etal: Metabolic and hemodynamic evaluation of gliomas using positron emission tomography.J Nucl Med 28: 1123–1133, 1987

    PubMed  CAS  Google Scholar 

  2. Bergh J, Nilsson S, Loljedahl C, etal: Radioimaging of human malignant glilomas using indium-labelled monoclonal antibodies.Nucl Med Comm 11: 437–444, 1990

    Article  CAS  Google Scholar 

  3. Claussen C, Lanaiado M, Kazner E, et al: Application of contrast agents in CT and MRI (NMR): their potential in imaging of brain tumors.Neuroradiol 27: 164–171, 1985

    Article  CAS  Google Scholar 

  4. Dooms GC, Hecht S, Brant-Zawadzki M, etal: Brain radiation lesions: MR imaging.Radiology 158: 149–155, 1986

    PubMed  CAS  Google Scholar 

  5. Beaney RP: Positron emission tomography in the study of human tumors.Sem Nucl Med 14: 324–341, 1984

    Article  CAS  Google Scholar 

  6. Coleman RE, Hoffman JM, Hanson MW, etal: Clinical application of PET for the evaluation of brain tumors.J Nucl Med 32: 616–622, 1991

    PubMed  CAS  Google Scholar 

  7. Di Chiro G, Hatazawa J, Katz DA, etal: Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study.Radiology 164: 521–526, 1987

    PubMed  Google Scholar 

  8. Yoshida J, Yamamoto R, Wakabayashi T, etal: Radioimmunoassay of glioma-associated antigen in cerebrospinal fluid and its usefulness for the diagnosis and monitoring of human glioma.J Neuro-Oncology 8: 23–31, 1990

    CAS  Google Scholar 

  9. Yoshida J, Mizuno M, Inoue I, etal: Radioimaging of human glioma xenografts with I labeled monoclonal antibody G-22 against glioma-associated antigen.J Neuro-Oncology 8: 221–229, 1990

    CAS  Google Scholar 

  10. Ito K, Kato T, Tadokoro M, etal: Recurrent rectal cancer and scar: differentiation with PET and MR imaging.Radiology 182: 549–552, 1992

    PubMed  CAS  Google Scholar 

  11. Dean BL, Drayer BP, Bird CR, etal: Gliomas: Classification with MR imaging.Radiology 174: 411–415, 1990

    PubMed  CAS  Google Scholar 

  12. Elster AD, Dipersio DA: Cranial postoperative site: assessment with contrast-enhanced MR imaging.Radiology 174: 93–98, 1990

    PubMed  CAS  Google Scholar 

  13. Di Chiro G: Positron emission tomography using [F-18] Fluoro-deoxyglucose in brain tumors. A powerful diagnostic and prognostic tool.Invest Radiol 22: 360–371, 1986

    Google Scholar 

  14. Di Chiro G, Oldfield E, Wright DC, etal: Cerebral necrosis after radiotherapy and/or intra-arterial chemotherapy for brain tumors: PET and neuropathologic studies.AJNR 8: 1083–1091, 1987

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oshima, M., Yoshida, J., Wakabayashi, T. et al. Recurrent malignant glioma: detection with131I labeled monoclonal antibody G-22, positron emission tomography and magnetic resonance imaging. Ann Nucl Med 7, 119–122 (1993). https://doi.org/10.1007/BF03164577

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03164577

Key words

Navigation